Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether resminostat will be able to delay or
prevent worsening of disease in patients with advanced stage mycosis fungoides or Sézary
Syndrome that have recently achieved disease control with previous systemic therapy.